Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
2.076
+0.076 (3.80%)
At close: Sep 15, 2025, 4:00 PM EDT
2.070
-0.006 (-0.29%)
After-hours: Sep 15, 2025, 6:35 PM EDT
Innate Pharma Employees
Innate Pharma had 181 employees as of December 31, 2024. The number of employees increased by 2 or 1.12% compared to the previous year.
Employees
181
Change (1Y)
2
Growth (1Y)
1.12%
Revenue / Employee
$115,090
Profits / Employee
-$282,970
Market Cap
197.08M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 181 | 2 | 1.12% |
| Dec 31, 2023 | 179 | -32 | -15.17% |
| Dec 31, 2022 | 211 | -4 | -1.86% |
| Dec 31, 2021 | 215 | -29 | -11.89% |
| Dec 31, 2020 | 244 | 9 | 3.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IPHA News
- 1 day ago - Innate Pharma Announces Its Participation in the 25th Edition of the European Midcap Event - Business Wire
- 5 days ago - Innate Pharma Announces Conference Call and Webcast for First Half 2025 Financial Results and Business Update - Business Wire
- 7 weeks ago - Innate Pharma Announces Its Participation in the BTIG Virtual Biotechnology Conference - Business Wire
- 3 months ago - Innate Pharma Announces Its Participation in H.C. Wainwright and Wolfe Research Healthcare Conferences - Business Wire
- 3 months ago - Innate Pharma Highlights Preclinical Antitumor Activity of IPH6501 in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma at the 2025 European Hematology Association (EHA) Congress - Business Wire
- 4 months ago - Innate Pharma Announces Its Participation in Jefferies and Goldman Sachs Healthcare Conferences - Business Wire
- 4 months ago - Innate Pharma Highlights Durable Responses to Lacutamab in Sezary Syndrome and Mycosis Fungoides - Business Wire
- 4 months ago - Outcome of Innate Pharma's 2025 Annual General Meeting - Business Wire